Related Experiment Video
Updated: May 15, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Association Between In-Hospital Antibiotic Use and Long-Term Outcomes in Critically Ill Patients
Parker Burrows1, Ruth-Ann Brown1, Abigail Samuelsen2
1Department of Anesthesiology and Perioperative Medicine, Penn State Milton S Hershey Medical Center, Hershey, PA 17036, USA.
Objective:
To assess whether antibiotic duration (AD) and one-year antibiotic-free days (AFD) are associated with key in-hospital and post-discharge outcomes among critically ill adults.
Design:
Retrospective observational study.
Setting:
Quaternary care academic medical center in the United States.
Patients:
A total of 126 critically ill adults, mean age 68.1 years (±15.6), 51.6% male, median APACHE II score of 20.5 (IQR 15-25); 71.4% met sepsis criteria.
Methods:
Patient demographics, clinical characteristics, antibiotic use, and outcomes were collected over one year. Secondary infection was defined as ≥3 consecutive antibiotic days within a year following the index sepsis admission. Multivariate analyses adjusted for age, APACHE II score, gender, and glucocorticosteroid dose.
Results:
Within 30 days, longer AD correlated with increased hospital stay (p<0.001) with each additional day of antibiotics associated with 0.37 - 0.39 extra days of hospitalization in univariate and multivariate analyses, respectively. In septic patients specifically, AFD significantly correlated with hospital length-of-stay in both univariate (p=0.023) and multivariate analyses (p=0.002), with no impact from infection type on AD or AFD. Fewer AFD correlated with higher secondary bacteremia rates in unadjusted analysis (p=0.023 overall), but this effect was not significant after multivariable adjustment. Neither AD nor AFD predicted one-year mortality or readmission.
Conclusions:
Extended antibiotic duration in critically ill patients prolonged hospital stays without providing mortality or readmission benefits. These findings underscore the importance of robust antibiotic stewardship, where shorter, targeted regimens can reduce unintended complications and improve overall outcomes.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
06:28Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...